Skip 
Navigation Link
Child Development & Parenting: Early (3-7)
Resources
Basic Information
Development During Early Childhood, Toddler, and Preschool Stages Parenting Your Todder, Preschooler, and Young ChildToilet TrainingDisciplining Your Toddler, Preschooler, and Young ChildNurturing Your Toddler, Preschooler, and Young Child
Latest News
Could You Raise a 'No-Diaper' Baby?Health Tip: Children and ThumbsuckingWhen Parents Focus on Smartphones, Kids' Misbehaving Can RiseHealth Tip: Inspect Your Child's PlaygroundToddlers Who Drink Cow's Milk Alternatives May Be ShorterPreschoolers Who Know Snack-Food Brands on Road to Obesity?Playgrounds Aren't Always All Fun and GamesPrevalence of Visual Impairment in Preschoolers Expected to RiseUntreated Vision Problems Plague U.S. PreschoolersPoorer Kindergarteners Face a 'Double Dose of Disadvantage'PAS: Screen Time Affects Speech Development in Young ChildrenReading to Babies Translates Into More Literate PreschoolersA Toddler's Screen Time Tied to Speech DelayU.S. Toddlers Eat More French Fries Than VegetablesBrineura Approved for Rare Genetic Illness Affecting KidsHealth Tip: When Kids Feel AnxiousTiming of Lunch, Recess May Determine What Kids EatIs Kindergarten the New First Grade?Health Tip: Transitioning Toddlers to One NapHow to Protect Your Child From Accidental PoisoningBreast-Feeding May Not Lead to Smarter PreschoolersInjury Risk May Rise When Kids Play Just One SportPoor Sleep in Preschool Years Could Mean Behavior Troubles LaterRising Number of Kids Ill From Drinking Hand Sanitizers: CDCDoes TV Hinder Kindergarten-Readiness?Task Force Recommends Vision Screening in Children 3 to 5Kids Should Be Screened for Lazy Eye by Age 5Health Tip: Encouraging Picky EatersNaps May Sharpen a Preschooler's Language SkillsPet Meds Sending Kids to the ERLaundry Detergent Pods Linked to Eye Burn Danger in KidsHealth Tip: Is Your Toddler Eating Enough?Health Tip: Help Young Children Make Healthy ChangesFlameless Candle Batteries Pose Risk to KidsHealth Tip: Skip Winter Coats in Car SeatsCan Parents' Weight Hinder Toddlers' Development?Christmas Cords Pose Danger to Little OnesDon't Forget Child Safety When Traveling for the HolidaysHoliday Decor Can Be HazardousChild Deaths Highlight Choking Dangers Posed by GrapesHealth Tip: Help Toddlers Develop Stronger HandsConsider Eye Safety When Choosing Kids' ToysHealth Tip: Make Brushing Teeth FunFew Preschoolers Receiving Tx for Mood, Behavioral DisordersHealth Tip: Keep Kids Safe During the HolidaysTroubled Preschoolers Not Getting Effective Treatment: ReportTV Snack Ads Make Preschoolers Snack More: StudySafety Group Releases Annual Dangerous Toys ListGuidelines May Have Helped Curb ADHD Diagnoses in PreschoolersKids React Differently When a Beloved Pet Dies
LinksBook Reviews
Related Topics

Child & Adolescent Development: Overview
Childhood Mental Disorders and Illnesses
Parenting
Child Development & Parenting: Infants (0-2)
Child Development & Parenting: Middle (8-11)

Brineura Approved for Rare Genetic Illness Affecting Kids

HealthDay News
by -- Scott Roberts
Updated: Apr 28th 2017

FRIDAY, April 28, 2017 (HealthDay News) -- Brineura (cerliponase alfa) has been approved by the U.S. Food and Drug Administration to treat a specific form of Batten Disease, a rare set of genetic disorders that typically begin in childhood between ages 2 and 4, the agency said in a news release.

Initial symptoms of the CLN2 form of Batten, for which the drug is approved, usually include language delay, seizures and coordination problems. Affected children also develop vision loss and motor-skill issues, including trouble walking. Many require a wheelchair by late childhood and often don't survive past their teens, the agency said.

Batten is rare, occurring in as many as four of every 100,000 births in the United States. Brineura is an enzyme replacement drug; its primary ingredient is a lab-developed form of the human enzyme TPP1, administered directly into the cerebrospinal fluid by means of a surgically implanted reservoir, the FDA said.

Brineura was evaluated in clinical studies involving 24 children ages 3 to 8 with CLN2 disease. The most common side effects included fever, heart problems, vomiting, seizures, headache and irritability.

The drug hasn't been evaluated in children under age 3, the FDA said. As a condition of approval, its manufacturer will be required to evaluate the drug in younger children, and to study for a minimum of 10 years its long-term health effects.

Approval of Brineura was given to BioMarin Pharmaceutical, based in San Rafael, Calif.

More information

The FDA has more about this approval.